This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sexual Dysfunction Linked To Antidepressant Use In Female Patients

NEW YORK, Feb. 19, 2013 /PRNewswire/ -- According to a recent study conducted at the Postgraduate Institute of Medical Education and Research in Chandigarh, India, 42.5% of married female patients experience sexual dysfunction associated with antidepressant use I.

(Logo: http://photos.prnewswire.com/prnh/20120717/NY41829)

The study used a Female Sexual Function Index scale to assess the sexual function of eighty married female patients, all of which were diagnosed with a depressive disorder and were currently in remission and receiving a single antidepressant. Patients were asked to complete a 19-item self-report questionnaire, which targeted key dimensions of sexual functioning – desire, arousal, lubrication, orgasm, satisfaction, and pain – in addition to answering questions regarding their self-perceived sexual dysfunction.

Although the incidence and prevalence of sexual dysfunction vary depending on a number of factors, the general consensus is that 30-65% of patients experience sexual dysfunction while receiving selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and monoamine oxidase inhibitors. Sexual dysfunction can range from lack of desire to vaginal dryness and pain. Not only does this affect a women's physical wellbeing, but it also impacts their self-esteem and intimate relationships. In addition, patients who experience sexual dysfunction often discontinue their medication, jeopardizing their mental health.

Despite the known prevalence, sexual effects of antidepressant medication are often not addressed.  To help moisturize and soothe the vulva, patients taking SSRI, SNRI and MAOI medications can use NeoGyn Vulvar Soothing Cream. The cream helps restore vulvar skin without estrogens. NeoGyn relies on a scientific formulation of cutaneous lysate, a novel ingredient discovered in Switzerland after years of wound healing research.

About Neogyn®:Neogyn® Vulvar Soothing Cream is a cosmetic product to help soothe and comfort the vulva. Formulated with Cutaneous Lysate, a naturally balanced blend of proteins discovered in Switzerland, the product is non-greasy, fast absorbing and free of color additives, fragrances and analgesics. Recommended by physicians and women's health professionals, Neogyn® has a unique, patent pending blend of naturally balanced proteins that help restore well-being and comfort with twice daily use over a period of at least 6 to 8 weeks.

RELATED LINKS http://www.neogyn.us

I. Grover S, Shah R, Dutt A, Avasthi A. Prevalence and Pattern of Sexual Dysfunction in Married Females Receiving Antidepressants: An Exploratory Study. J Pharmacol Pharmacother 2012 [cited 2013 Feb 12];3:259-65. Available from: http://www.jpharmacol.com/text.asp?2012/3/3/259/99430

SOURCE NeoGyn

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs